EPI Program Achievements

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
N03AA02	GARDENAL	B	Phenobarbital - 100mg	100mg	Tablet	120,946 L.L
A03FA07	GAROPRIDE	G	Itopride Hydrochloride - 50mg	50mg	Tablet, film coated	213,671 L.L
A02BC01	GASTRAZOLE	G	Omeprazole - 20mg	20mg	Capsule	245,923 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	427,342 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	6,720,556 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	503,941 L.L
A02BC01	GASTRIMUT	G	Omeprazole - 40mg	40mg	Capsule, hard, gastro-resistant	956,816 L.L
A02BC01	GASTRISEC	G	Omeprazole - 20mg	20mg	Capsule	413,903 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
A02BX13	GAVISCON	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 267mg/10ml, Calcium (carbonate) - 160mg/10ml		Liquid	295,645 L.L
A02BX13	GAVISCON ADVANCE ANISEED FLAVOR	B	Sodium alginate - 1000mg/10ml, Potassium hydrogen carbonate - 200mg/10ml		Suspension	514,692 L.L
A02BX13	GAVISCON DOUBLE ACTION	B	Sodium alginate - 500mg, Sodium bicarbonate - 213mg, Calcium (carbonate) - 325mg		Suspension	517,379 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 250mg, Sodium bicarbonate - 106.5mg, Calcium (carbonate) - 187.5mg		Tablet, chewable	456,906 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 213mg/10ml, Calcium (carbonate) - 325mg/10ml		Suspension	542,912 L.L
A02BX13	GAVISCON INFANT	B	Sodium alginate - 225mg, Magnesium alginate - 87.5mg		Powder for suspension	710,893 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	314,437,416 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	85,330,070 L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	87,070,893 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
B05AA06	GELASPAN	B	Gelatine, succinylated - 4%	4%	Injectable solution	9,107,572 L.L
L01BC05	GEMCI-CELL	G	Gemcitabine (HCl) - 1g/Vial	1g/Vial	Injectable concentrate for solution	9,326,123 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 200mg/20ml	200mg/20ml	Injectable concentrated solution	2,121,927 L.L
L01BC05	GEMCITABIN EBEWE	G	Gemcitabine (HCl) - 1g/100ml	1g/100ml	Injectable concentrated solution	7,512,674 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 200mg	200mg	Injectable powder for solution	1,490,321 L.L
L01BC05	GEMCITABINE NEAPOLIS	G	Gemcitabine (HCl) - 1000mg	1000mg	Injectable powder for solution	4,942,653 L.L

إنجازات البرنامج